Alembic's Aleor joint venture gets FDA approval for generic ClobexClobetasol propionate spray, 0.05%, had a market value of roughly $22 million for the 12 months ended December 2018, according to IQVIA. Foamix reaches litigation settlement with Teva on Finacea FoamFoamix and LEO Pharma have reached a settlement agreement with Teva on patent litigation involving Finacea Foam. It follows a settlement in April with Perrigo. FDA approves Teligent’s gentamicin sulfate cream Gentamicin sulfate cream, 0.1% has a market value of roughly $15.6 million, according to IQVIA October data. Glenmark gets FDA OK for generic Zytiga Zytiga tablets, 250 mg had a market value of $794.1 million for the 12 month period ended August 2019, according to IQVIA. ANI launches generic Aggrenox Aspirin and extended-release dipyridamole capsules have a market value of roughly $80 million. Akorn gets FDA nod for betamethasone dipropionate Betamethasone dipropionate lotion (augmented), 0.05% had a market value of approximately $10 million for the 12 months ended August 2019, according to IQVIA. Zydus Cadila receives FDA nod for generic Welchol The FDA has approved Zydus Cadila's generic cholesterol-lowering drug. Glenmark gets tentative FDA nod for generic Tecfidera Tecfidera capsules, 120 mg and 240 mg had a market value of approximately $3.7 billion for the 12 months ended in August 2019. Amneal launches generic Invega Paliperidone extended-release tablets had a market value of approximately $373 million for the 12 months ended July 31. Alembic intros generic Lumigan First Previous 174 175 176 177 178 Next Last
